Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders

Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders

Proceedings of a Workshop

Mitwirkender: Stroud, Clare; Bain, Lisa; Matney, Chanel; Norris, Sheena M Posey
Versandkostenfrei!
Versandfertig in über 4 Wochen
15,99 €
inkl. MwSt.
PAYBACK Punkte
8 °P sammeln!
Psychiatric illnesses - such as major depressive disorder, anxiety disorder, substance use disorder, and posttraumatic stress disorder (PTSD) - are widely prevalent and represent a substantial health burden worldwide. Yet, conventional medications for mental illnesses often fail to provide relief to patients' disruptive and disabling symptoms. Existing and emerging evidence that psychedelics (e.g., LSD and psilocybin) and entactogens (e.g., MDMA) may be useful as tools to alleviate mental illness has sparked a renaissance of interest by investigators, clinicians, drug developers, and patient a...